TSG101 Antikörper
-
- Target Alle TSG101 Antikörper anzeigen
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser TSG101 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody reacts to TSG101.
- Aufreinigung
- Protein A chromatography
- Immunogen
- TSG101 antibody was raised against recombinant protein
- Klon
- 5B7
- Isotyp
- IgG2a
- Top Product
- Discover our top product TSG101 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0,5 mg/mL
- Buffer
- PBS, pH 7.2
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
- Andere Bezeichnung
- TSG101 (TSG101 Produkte)
- Hintergrund
- The tumor susceptibility gene 101 (TSG101) was first discovered in a screen for potential tumor suppressors. Altered transcripts of this gene have been detected in sporadic breast carcinomas and other malignancies. In mice the gene has been shown to be essential for growth, proliferation and survival of mammary epithelial cells. TSG101 is also a component of the ESCRt-1 complex, a regulator of the vesicular trafficking process. In addition it is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies and is involved the budding of many viruses.Synonyms: ESCRT-I complex subunit TSG101, Tumor susceptibility gene 101 protein
- Gen-ID
- 7251
- NCBI Accession
- NP_006283
- UniProt
- Q99816
-